Do You Lose More Weight on Mounjaro or Ozempic?

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When comparing Mounjaro (tirzepatide) and Ozempic (semaglutide) for weight loss, the clinical data shows tirzepatide produces larger average weight reductions—up to 22% of body weight versus 15% for semaglutide at their highest doses. However, individual results vary based on metabolism, genetics, and adherence. PlexusDx offers compounded versions of both medications plus a Precision Peptide Genetic Test that identifies which pathway—GLP-1 or GIPR—your body may respond to most effectively.

Tirzepatide vs Semaglutide: Clinical Weight Loss Comparison

Tirzepatide and semaglutide both reduce appetite and improve blood sugar control, but they work through different mechanisms. Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIPR (glucose-dependent insulinotropic polypeptide) receptors. This dual-pathway activation in tirzepatide has been shown to produce greater average weight loss in head-to-head trials.

In the SURMOUNT clinical trial series, tirzepatide at its highest dose (15 mg weekly) led to average weight loss of 20.9% of body weight over 72 weeks. By comparison, semaglutide at its highest dose (2.4 mg weekly) achieved approximately 14.9% average weight loss in the STEP trials over similar timeframes. These differences suggest tirzepatide may offer a stronger tool for individuals seeking maximum weight reduction.

Individual response rates vary significantly because genetics, insulin sensitivity, and existing metabolic conditions influence how your body responds to each medication. Some patients achieve excellent results on semaglutide alone, while others see superior outcomes when switching to tirzepatide or starting with it first. This is why genetic insight matters when selecting your starting therapy.

How the Dual Mechanism of Tirzepatide Boosts Weight Loss

The GIPR receptor pathway activated by tirzepatide plays a distinct role in appetite suppression and energy expenditure that semaglutide cannot address. When both GLP-1 and GIPR pathways are stimulated simultaneously, patients often experience more sustained satiety, reduced late-night food cravings, and improved metabolic flexibility. This combined effect explains why some individuals lose weight faster and maintain loss more effectively on tirzepatide.

Research suggests GIPR activation may also enhance insulin secretion in response to meals and improve how the body processes glucose, creating a metabolic advantage beyond appetite reduction alone. For individuals with insulin resistance or type 2 diabetes history, this dual action can yield more pronounced improvements in both weight and blood sugar metrics.

PlexusDx's Precision Peptide Genetic Test examines genetic variants in the GIPR and GLP1R genes (including rs1800437 and rs6923761) to predict which receptor pathway your body may respond to most favorably, helping guide whether tirzepatide or semaglutide is the better starting choice for your unique metabolism.

Who Loses More Weight: Patient Factors Beyond Medication Type

Medication choice is only one factor in weight loss success. Baseline body mass index, age, diet quality, exercise consistency, sleep patterns, and stress management all influence how much weight you ultimately lose. A patient on semaglutide who maintains strict caloric intake and exercises regularly may outperform someone on tirzepatide who makes no lifestyle changes.

Adherence matters significantly as well. Tirzepatide requires weekly injections, while oral tirzepatide (available through PlexusDx) offers convenience for patients who prefer not to inject. Similarly, oral semaglutide suits patients with needle anxiety. The medication you'll actually take consistently often produces better results than a theoretically 'stronger' option you struggle to use.

Dose escalation also plays a role—maximum weight loss typically occurs at higher doses, but some individuals plateau or experience side effects before reaching peak doses. PlexusDx offers multiple formulation options including Compounded Tirzepatide Injection (starting at $249/mo), Oral Tirzepatide (starting at $279/mo), and the GLP-Squared Injection combining both compounds (starting at $249/mo for dual therapy).

Starting Treatment: Tirzepatide or Semaglutide Through PlexusDx

PlexusDx makes both medications accessible across all 50 states without insurance requirements or membership fees. Compounded Semaglutide Injection starts at $149/mo, while Compounded Tirzepatide Injection begins at $249/mo. Your dose may increase over time as your body builds tolerance, but PlexusDx's pricing model keeps monthly costs flat—your dose may go up, but your price won't.

If you're uncertain which medication aligns with your genetic predispositions, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first treatment month). This test analyzes 14 metabolic pathways and 49 peptides, examining key variants like FTO rs9939609 and MC4R rs17782313 that influence appetite set-point and energy regulation. Results help your provider optimize medication selection and predict long-term response.

All medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and safety. HSA and FSA funds are eligible for both medications and genetic testing, reducing out-of-pocket costs. PlexusDx's team can discuss whether to start with tirzepatide for maximum weight loss potential, semaglutide for a gentler introduction, or even the GLP-Squared dual-compound approach.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I expect to lose 20% of my body weight on tirzepatide like the clinical trials show?

Clinical trials represent best-case scenarios with highly selected participants who adhered perfectly to protocol. Real-world weight loss varies—most patients lose 10–18% on tirzepatide when combined with modest dietary changes. Your genetics, starting weight, age, and lifestyle determine your personal outcome. PlexusDx's Precision Peptide Genetic Test can help predict your individual response trajectory.

Is tirzepatide always better for weight loss than semaglutide?

Not necessarily. While tirzepatide achieves greater average weight loss in trials, some patients respond equally well or better to semaglutide due to genetic differences in GLP-1 receptor sensitivity. The GIPR pathway that tirzepatide activates doesn't benefit everyone equally. Genetic testing or a trial period can help determine which medication suits your metabolism.

How much does tirzepatide cost monthly through PlexusDx?

PlexusDx's Compounded Tirzepatide Injection starts at $249/month flat, with no per-dose increases. Oral Tirzepatide starts at $279/month. Both are eligible for HSA/FSA funds, and all 50 states are served without insurance requirements. Your dose may increase during treatment, but your monthly price remains the same.

What side effects should I expect, and do they differ between tirzepatide and semaglutide?

Both medications commonly cause nausea, reduced appetite, and mild gastrointestinal effects during the first 2–4 weeks. Tirzepatide may produce slightly more GI effects due to its dual-pathway activation, but most side effects fade with continued use. Serious complications are rare. Talk to your PlexusDx provider about managing side effects and whether a dose adjustment helps.

What does the Precision Peptide Genetic Test reveal about my weight loss potential?

PlexusDx's Precision Peptide Genetic Test examines 150+ genetic insights across 14 metabolic pathways, including GLP1R and GIPR variants that influence appetite sensitivity and satiety response. Results predict whether you're more likely to respond to GLP-1 pathway activation (favoring semaglutide) or dual-pathway activation (favoring tirzepatide), plus insights on FTO and MC4R variants affecting baseline appetite regulation. This $99 add-on test (after your first month) personalizes your treatment plan.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.